These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Successful management of patients with a drug-eluting coronary stent presenting for elective surgery. Bengeri S Br J Anaesth; 2007 Jun; 98(6):841; author reply 841-2. PubMed ID: 17519264 [No Abstract] [Full Text] [Related]
7. [Developments in percutaneous coronary intervention and coronary stents]. Simsek C; Daemen J; Zijlstra F Ned Tijdschr Tandheelkd; 2014; 121(7-8):375-9. PubMed ID: 25174186 [TBL] [Abstract][Full Text] [Related]
8. The influence of low (81 mg) versus high (325 mg) doses of ASA on the incidence of sirolimus-eluting stent thrombosis. Joyal D; Freihage JH; Cohoon K; Tempelhof M; Leya F; Dieter RS; Steen L; Lewis B; Arab D J Invasive Cardiol; 2007 Jul; 19(7):291-4. PubMed ID: 17620672 [TBL] [Abstract][Full Text] [Related]
9. The perioperative management of patients with coronary artery stents: surveying the clinical stakeholders and arriving at a consensus regarding optimal care. Vetter TR; Boudreaux AM; Papapietro SE; Smith PW; Taylor BB; Porterfield JR Am J Surg; 2012 Oct; 204(4):453-461.e2. PubMed ID: 22621834 [TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of biodegradable polymer-coated sirolimus-eluting stents in "real-world" practice: 18-month clinical and 9-month angiographic outcomes. Han Y; Jing Q; Xu B; Yang L; Liu H; Shang X; Jiang T; Li Z; Zhang H; Li H; Qiu J; Liu Y; Li Y; Chen X; Gao R; JACC Cardiovasc Interv; 2009 Apr; 2(4):303-9. PubMed ID: 19463441 [TBL] [Abstract][Full Text] [Related]
11. Long-term safety of drug-eluting stents. Riede FN; Pfisterer M; Jeger R Expert Rev Cardiovasc Ther; 2013 Oct; 11(10):1359-78. PubMed ID: 24138523 [TBL] [Abstract][Full Text] [Related]
12. [Coronary stents and anaesthesia: it is time to have national data]. Vichova Z; Albaladejo P; Marret E; Lehot JJ; Monier F; Marcotte G; Samama CM; Piriou V Ann Fr Anesth Reanim; 2007 Feb; 26(2):157-60. PubMed ID: 17188455 [TBL] [Abstract][Full Text] [Related]
13. Propensity-matched lesion-based comparison of midterm outcomes of TAXUS Express and TAXUS Liberté stents for de novo native coronary stenosis. Ishikawa T; Nakano Y; Hino S; Suzuki T; Murakami A; Tsutsumi J; Miyamoto T; Mutoh M J Cardiol; 2013 Nov; 62(5):289-95. PubMed ID: 23806548 [TBL] [Abstract][Full Text] [Related]
14. Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: a prospective single-center registry in high-risk patients. Miglionico M; Patti G; D'Ambrosio A; Di Sciascio G Catheter Cardiovasc Interv; 2008 Apr; 71(5):600-4. PubMed ID: 18360849 [TBL] [Abstract][Full Text] [Related]